IgniteRF is the complete minimally invasive soft tissue contraction platform. It supports procedures requiring soft tissue contraction, electrocoagulation, hemostasis, and fractional treatments with penetration depths up to 60mm.

Featuring QuantumRF and Morpheus8 technologies, this expandable system grows with your practice.

The body aesthetics market, valued at $1.5B in 2023, is projected to reach $9.4B by 2032 (23.1% CAGR). 

IgniteRF enables you to tap into this growth by expanding your patient base to include gap patients ineligible for traditional surgery, sideline patients avoiding invasive procedures, and post-surgical maintenance patients.

IgniteRF combines QuantumRF and Morpheus8 technologies to deliver deep tissue treatments up to 60mm. The system features advanced Polymer coated QuantumRF handpieces that deploy clinically proven fractionated radiofrequency for efficient, safe procedures with shorter downtimes.

DR. F. HAMADANI

DR. T. MANINGAS

DR. P. ROVATTI

IgniteRF is a multi-functional platform that includes:

• New QuantumRF 10 and QuantumRF 25 handpieces, cleared for soft tissue contraction by deploying clinically proven fractionated radiofrequency to maximal depths. The Teflon coated, lightweight handpieces, deliver deep, pulsed bipolar RF to areas without damaging the dermis, resulting in shorter downtimes and safer procedures.

• New Morpheus8 and Morpheus8 Deep applicators, indicated for soft tissue contraction and equipped with enhanced functionalities to provide you with greater versatility.

With IgniteRF, you can deliver customized combination procedures, putting more innovative control in your hands.

QuantumRF 10 on the Face

Live Demonstration 

QuantumRF 25 on the Abdomen 

Live Demonstration

Precision and Innovation: Morpheus8 in Action | Live Treatment with Dr. Ashkan Ghavami

Designed for plastic surgeons who want to grow revenue while offering patients dramatic results without large incisions, InMode's QuantumRF and RFAL technologies such as BodyTite, FaceTite and AccuTite deliver both impact and income.

Providers report $3,000–$5,000 per facial case and $5,000–$10,000 per body case, depending on treatment area.

Generate a minimum of $3,500 per face or small-area treatment, and $5,500 or more for large body areas.

Most practices recoup their initial investment with just 3–4 RFAL procedures per week.

Disclaimer: Revenue figures are estimates based on average treatment pricing and patient volume. Actual results may vary by clinic.

IgniteRF is a multi-functional platform that includes a redesigned portfolio of clinically proven RFAL technologies.

• Flexible Growth Path: Begin with QuantumRF or Morpheus8 capabilities and seamlessly add other treatment modalities as your practice evolves.
  

• Practice Scalability: Add new treatment capabilities without replacing your entire system, maximizing return on investment.

• Customizable Solutions: Build your ideal treatment suite over time, adding handpieces that match your growing patient demands.

• Deep tissue contraction
• Body treatments
• Soft tissue treatments
• Face and neck treatments
• Post-surgical maintenance
• Early laxity treatment

• QuantumRF 10 and 25 handpieces
• Morpheus8 technology
• Treatment depth up to 60mm
• Real-time thermal monitoring
• Customizable RF delivery
• Minimal downtime protocols
• Multi-functional platform capabilities

Get a call from our dedicated concierge team to learn more about how InMode's IgniteRF can benefit your practice and your patients.

Not all products are approved in all countries. Check availability and approved intended use with our local representative.

Clinical and peer-reviewed publications are published by a third party and based on physician experiences and study results. InMode does not take responsibility for or endorse the content provided by the independent practitioners as the language may differ than InMode manufacturer clearances.

17 Hughes

Irvine CA 92618